查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1391984

医用益生菌市场：按成分类型、配销通路和地区

Medical Probiotics Market, By Ingredient Type, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3个工作天内

价格
简介目录

医用益生菌市场规模预计将从 2023 年的 405 亿美元增至 2030 年的 622.5 亿美元，预测期内复合年增长率为 6.3%。

报告范围 报告详情
基准年 2022年 2023年市场规模 405亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期复合年增长率 6.30% 2030年市场规模预测 622.5亿美元
图 1. 2023 年按地区分類的医用益生菌全球市场占有率(%)
医用益生菌市场-IMG1

医用益生菌因其潜在的健康益处而受到广泛关注。益生菌是对人体特别是消化器官系统有益的活菌或酵母。它们天然存在于优格、酸菜和其他发酵产品等食品中。另一方面，医用益生菌经过专门配製，可提供有针对性的健康益处。

由于人们对肠道健康重要性的认识不断提高、慢性病患病率上升以及对自然和预防性医疗保健解决方案的需求不断增长，医用益生菌市场正在快速增长。有以下因素。众所周知，医用益生菌可以支持消化并增强免疫系统，使其成为传统药物的有吸引力的替代品。

市场动态：

预计医用益生菌市场在预测期内将显着成长。该市场的主要驱动因素包括消费者对自然和预防性医疗保健选择的需求不断增加、慢性病患病率上升以及对肠道健康与整体健康之间联繫的日益了解。例如，

然而，也存在阻碍市场成长的因素。主要挑战是缺乏有关医用益生菌的使用和标籤的标准化法规。因此，消费者和医疗保健专业人士对这些产品的有效性和安全性缺乏信心。此外，医用益生菌的高价格以及仅在某些地区提供产品也可能阻碍市场成长。

儘管面临这些挑战，医用益生菌市场仍存在一些成长机会。益生菌相关研发（R＆D）活动的​​增加、益生菌产品生产和市场开拓的技术进步以及医用益生菌应用领域的扩大是推动市场成长的因素之一。

本研究的主要特点

  • 本报告对医用益生菌市场进行了详细分析，包括以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
  • 它揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的资讯。
  • 医用益生菌市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析医用益生菌市场的各种策略矩阵，将有助于相关人员做出决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 假设
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素
  • 增加女性健康产品的推出
    • 抑制因素
  • 研发成本高、监管严格
    • 机会
  • 设施扩建
  • 主要亮点
  • 监管场景
  • 最近的趋势
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 合併、收购和合作

第四章医用益生菌市场－冠状病毒（COVID-19）大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第五章 医用益生菌市场，依成分类型，2018-2030

  • 细菌
  • 乳酸菌
  • 双歧桿菌
  • 链球菌
  • 芽孢桿菌属
  • 酵母菌
  • 孢子形成剂
  • 其他的

第六章 医用益生菌市场，依应用分类，2018-2030

  • 益生菌食品饮料
  • 乳製品
  • 非乳製品饮料
  • 连续剧
  • 烘焙点心
  • 发酵肉品
  • 益生菌食品营养补充
  • 益生菌有益女性健康
  • 婴幼儿配方奶粉
  • 其他的

第 7 章 医用益生菌市场，依配销通路，2018-2030

  • 大型超市/超级市场
  • 药局/药局
  • 专卖店
  • 线上销售

第八章 2018-2030 年医用益生菌市场（按地区）

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 德国
  • 英国
  • 西班牙
  • 俄罗斯
  • 义大利
  • 法国
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • ASEAN
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 南非
  • 北非
  • 中部非洲

第9章竞争形势

  • 公司简介
    • Probi AB
    • Abbott
    • Lonza
    • Hansen Holding A/S
    • Danone SA
    • Yakult Honsha Co., Ltd.
    • Nestle SA
    • DowDuPont Inc.
    • Kerry Group plc
    • BioGaia AB
    • DSM
    • Sun Genomics
    • Evonik
    • Probiotics International Limited（Protexin）
    • UAS Laboratories LLC
    • Analysts'Views

第10章

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6438

The medical probiotics market size is expected to reach US$ 62.25 Bn by 2030, from US$ 40.50 Bn in 2023, at a CAGR of 6.3% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 40.50 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 6.30% 2030 Value Projection: US$ 62.25 Bn
Figure 1. Global Medical Probiotics Market Share (%), By Region, 2023
Medical Probiotics Market - IMG1

Medical probiotics have gained significant attention due to their potential health benefits. Probiotics are live bacteria and yeasts that are beneficial for the human body, especially for the digestive system. They are found naturally in foods like yogurt, sauerkraut, and other fermented products. Medical probiotics, on the other hand, are specifically formulated to provide targeted health benefits.

The g medical probiotics market is growing rapidly, which is driven by factors such as the increasing awareness about the importance of gut health, rising prevalence of chronic diseases, and the growing demand for natural and preventive healthcare solutions. Medical probiotics are known to support digestion and boost the immune system, thus making them an attractive alternative to traditional medicines.

Market Dynamics:

The medical probiotics market is expected to witness significant growth during the forecast period. The key drivers of this market include the increasing consumer demand for natural and preventive healthcare options, the rising incidence of chronic diseases, and the growing understanding of the link between gut health and overall well-being.

However, there are also certain restraints that may hinder the market growth. The major challenges are the lack of standardized regulations governing the use and labeling of medical probiotics. This leads to a lack of confidence among consumers and healthcare professionals regarding the efficacy and safety of these products. The high cost of medical probiotics and the limited availability of products in certain regions may also impede the market growth.

Despite these challenges, the medical probiotics market presents several opportunities for growth. The increasing research and development (R&D) activities related to probiotics, advancements in technology for the production and delivery of probiotic products, and the expanding application areas of medical probiotics are some of the factors driving market growth.

Key Features of the Study:

  • This report provides in-depth analysis of the medical probiotics market, including market size (US$ Bn ) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • Key companies covered as a part of this study include Probi AB, Abbott, Lonza, Chr. Hansen Holding A/S, Danone S.A., Yakult Honsha Co., Ltd., Nestle S.A., DowDuPont Inc., Kerry Group plc, BioGaia AB, DSM, Sun Genomics, Evonik, Probiotics International Limited (Protexin), and UAS Laboratories LLC
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The medical probiotics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the medical probiotics market

Medical Probiotics Market Segmentation:

  • By Ingredient Type
    • Bacteria
    • Lactobacilli
    • Bifidobacterium
    • Streptococcus
    • Bacillus
    • Yeast
    • Spore Formers
    • Others
  • By Application
    • Probiotic Food & Beverages
    • Dairy Products
    • Non-dairy Beverages
    • Cereals
    • Baked Goods
    • Fermented Meat Products
    • Probiotic Dietary Supplements
    • Probiotics for Women's Health
    • Infant Formula
    • Others
  • By Distribution Channel
    • Hypermarkets/Supermarkets
    • Pharmacies/Drugstores
    • Specialty Stores
    • Online Sales
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East &Africa
  • Top Companies in Medical Probiotics Market:
    • Probi AB
    • Abbott
    • Lonza
    • Hansen Holding A/S
    • Danone S.A.
    • Yakult Honsha Co., Ltd.
    • Nestle S.A.
    • DowDuPont Inc.
    • Kerry Group plc
    • BioGaia AB
    • DSM
    • Sun Genomics
    • Evonik
    • Probiotics International Limited (Protexin)
    • UAS Laboratories LLC

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Ingredient Type
    • Market Snippet, By Application
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing product launches for women's health
    • Restraints
  • High R&D costs and stringent regulations
    • Opportunities
  • Facility expansion
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Medical Probiotics Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Medical Probiotics Market, By Ingredient Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019-2030
    • Segment Trends
  • Bacteria
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Lactobacilli
  • Bifidobacterium
  • Streptococcus
  • Bacillus
  • Yeast
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Spore Formers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Medical Probiotics Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019- 2030
    • Segment Trends
  • Probiotic Food & Beverages
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Dairy Products
  • Non-dairy Beverages
  • Cereals
  • Baked Goods
  • Fermented Meat Products
  • Probiotic Dietary Supplements
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Probiotics for Women's Health
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Infant Formula
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Medical Probiotics Market, By Distribution Channel, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019- 2030
    • Segment Trends
  • Hypermarkets/Supermarkets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Pharmacies/Drugstores
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mon)
  • Specialty Stores
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Online Sales
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Medical Probiotics Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Sub-region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Sub-region, 2019-2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Ingredient Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Ingredient Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • Germany
  • U.K.
  • Spain
  • Russia
  • Italy
  • France
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Ingredient Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Ingredient Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Ingredient Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Ingredient Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • South Africa
  • North Africa
  • Central Africa

9. Competitive Landscape

  • Company Profile
    • Probi AB
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • Abbott
    • Lonza
    • Hansen Holding A/S
    • Danone S.A.
    • Yakult Honsha Co., Ltd.
    • Nestle S.A.
    • DowDuPont Inc.
    • Kerry Group plc
    • BioGaia AB
    • DSM
    • Sun Genomics
    • Evonik
    • Probiotics International Limited (Protexin)
    • UAS Laboratories LLC
    • Analysts' Views

10. Section

  • References
  • Research Methodology
  • About us